{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:17:12Z","timestamp":1788790632442,"version":"build-2803163510"},"reference-count":158,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) commonly develops in the context of chronic liver injury and fibrosis, and its immune evasion and therapeutic resistance are shaped not only by tumor-intrinsic factors but also by persistent interactions between the tumor stroma and immune cells. Hepatic stellate cells (HSCs) represent an important source of cancer-associated fibroblasts (CAFs) in HCC. HSC-derived CAFs can restrict the infiltration and function of effector T cells and promote the accumulation of immunosuppressive cells through CAF-associated and multicellular signaling networks, including TGF-\u03b2\/SMAD, IL-6\/STAT3, CXCL12\/CXCR4, and CCL2\/CCR2, as well as through extracellular matrix remodeling, vascular abnormalities, hypoxia, and metabolic reprogramming. Importantly, mediators such as IL-6 and CCL2 are not specific to HSC-derived CAFs and can also be produced by immune cells, hepatocytes, and other cellular populations within the HCC microenvironment. Conversely, cytokines released by distinct T-cell subsets, including IL-17A, TGF-\u03b2, IL-10, IFN-\u03b3, and TNF-\u03b1, can in turn shape CAF activation, inflammatory states, and matrix-remodeling programs, thereby establishing a dynamic immune\u2013stromal feedback loop. Focusing on the heterogeneity of CAFs and T cells, this review systematically summarizes the major mechanisms underlying bidirectional crosstalk between HSC-derived CAFs and T cells and their stage-specific roles in chronic liver injury, HCC initiation, progression, and therapeutic resistance. We further discuss potential therapeutic strategies involving CAF modulation, stromal remodeling, combination immunotherapy, and patient stratification. Current evidence suggests that this crosstalk axis may provide an important framework for understanding immune exclusion and therapeutic resistance in HCC. However, its clinical translation remains constrained by CAF heterogeneity, limited targeting specificity, insufficient causal evidence in humans, and safety concerns in the setting of underlying liver disease.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1930718","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:20:04Z","timestamp":1788787204000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms and therapeutic strategies of bidirectional crosstalk between hepatic stellate cell-derived cancer-associated fibroblasts and T cells in immune evasion and therapeutic resistance of hepatocellular carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Kechuan","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The First People's Hospital of Wenling, Affiliated Wenling Hospital, Wenzhou Medical University","place":["Wenling, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlian","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First People's Hospital of Wenling, Affiliated Wenling Hospital, Wenzhou Medical University","place":["Wenling, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-03284-y","article-title":"CD44 upregulation in chronic liver disease marks the transition to hepatocellular carcinoma and portends poor prognosis","volume":"134","author":"Dong","year":"2026","journal-title":"Br J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-025-10838-y","article-title":"Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities","volume":"19","author":"Lin","year":"2025","journal-title":"Hepatol Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41419-025-07590-4","article-title":"Microenvironmental control of the ductular reaction: balancing repair and disease progression","volume":"16","author":"Sorrentino","year":"2025","journal-title":"Cell Death Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1773909","article-title":"Extracellular matrix stiffness in hepatocellular carcinoma: mechanisms and targeted therapeutic strategies","volume":"17","author":"Zhou","year":"2026","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3322\/caac.70018","article-title":"Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians","volume":"75","author":"Moris","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1581098","article-title":"Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances","volume":"16","author":"Xie","year":"2025","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1621812","article-title":"The tumor immune microenvironment: implications for cancer immunotherapy, treatment strategies, and monitoring approaches","volume":"16","author":"Racacho","year":"2025","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1827177","article-title":"Decoding the spatiotemporal dynamics of tumor immune niche remodeling in cancer immunotherapy","volume":"17","author":"Fu","year":"2026","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2024.165","article-title":"Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma","volume":"8","author":"Zhang","year":"2025","journal-title":"Cancer Drug Resist"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000004998","article-title":"SPP1+ neutrophil and exhausted CD8+ T cells infiltration predicting the early recurrence of hepatocellular carcinoma patients after R0 resection","author":"Luo","year":"","journal-title":"Int J Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40364-022-00406-z","article-title":"Advances of cancer-associated fibroblasts in liver cancer","volume":"10","author":"Peng","year":"2022","journal-title":"biomark Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00740-4","article-title":"CAF-induced physical constraints controlling T cell state and localization in solid tumours","volume":"24","author":"Arpinati","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12967-025-06744-4","article-title":"Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment","volume":"23","author":"Li","year":"2025","journal-title":"J Transl Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00549-7","article-title":"The advent of immune stimulating CAFs in cancer","volume":"23","author":"Tsoumakidou","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13045-026-01801-x","article-title":"Cytokines and cancer-associated fibroblasts","volume":"19","author":"Hu","year":"2026","journal-title":"J Hematol Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00977-x","article-title":"CAF-immune cell crosstalk and its impact in immunotherapy","volume":"45","author":"Maia","year":"2023","journal-title":"Semin Immunopathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32447","article-title":"Emerging immunotherapy for HCC: a guide for hepatologists","volume":"75","author":"Foerster","year":"2022","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12935-024-03518-8","article-title":"The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis","volume":"24","author":"Yu","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00747-z","article-title":"Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma","volume":"11","author":"Cheng","year":"2025","journal-title":"Cell Discov"},{"key":"B22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12967-025-06192-0","article-title":"Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000930","article-title":"Spatial and functional polarization of cancer-associated fibroblasts with CXCR4-mediated immune modulation in hepatocellular carcinoma","volume":"10","author":"Nakamura","year":"2026","journal-title":"Hepatol Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7150\/thno.99046","article-title":"DAB2+ macrophages support FAP+ fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer","volume":"14","author":"Long","year":"2024","journal-title":"Theranostics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-024-07195-3","article-title":"DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma","volume":"15","author":"Fan","year":"2024","journal-title":"Cell Death Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001386","article-title":"Hepatic stellate cell heterogeneity: functional aspects and therapeutic implications","author":"Geng","year":"","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","article-title":"The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine","volume":"24","author":"Su","year":"2025","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-026-01007-w","article-title":"Pleiotropic mechanisms of cancer-associated fibroblast-mediated resistance in hepatocellular carcinoma: emerging therapeutic vulnerabilities and targeting strategies","volume":"33","author":"Xie","year":"2026","journal-title":"Cancer Gene Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202510043","article-title":"Cancer-associated fibroblasts functions as multifunctional architects of the tumor stroma and represent emerging therapeutic vulnerabilities","volume":"13","author":"Liu","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70281","article-title":"Extracellular matrix signaling cues: biological functions, diseases, and therapeutic targets","volume":"6","author":"Zhao","year":"2025","journal-title":"MedComm (2020)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102395","article-title":"Insights into the relevance of targeting fibroblasts to control cancer","volume":"6","author":"Boeker","year":"2025","journal-title":"Cell Rep Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41467-024-55325-4","article-title":"Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution","volume":"16","author":"Watson","year":"2025","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07630-7","article-title":"A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection","volume":"631","author":"Bosch","year":"2024","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.10.044","article-title":"Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Kim","year":"2025","journal-title":"J Hepatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02255-y","article-title":"Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis","volume":"26","author":"Martin","year":"2025","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-025-02370-2","article-title":"Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC","volume":"24","author":"Huang","year":"2025","journal-title":"Mol Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26188788","article-title":"Cytotoxic T cells: kill, memorize, and mask to maintain immune homeostasis","volume":"26","author":"Kumar","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cells15040350","article-title":"The role of CD4+ T helper cell subsets in hepatocellular carcinoma: implications for tumour progression and immunotherapy","volume":"15","author":"Shao","year":"2026","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.20892\/j.issn.2095-3941.2025.0414","article-title":"CD4+ T cells in cancer: dual roles, exhaustion, and therapeutic breakthroughs","volume":"23","author":"Zhang","year":"2026","journal-title":"Cancer Biol Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167836","article-title":"Immunological landscape and molecular therapeutic targets of the tumor microenvironment in hepatocellular carcinoma","volume":"26","author":"Zarlashat","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/cells15121097","article-title":"Immunotherapy and hepatocellular carcinoma: from tumor-immune cell interactions to rational therapeutic strategies","volume":"15","author":"Yuza","year":"2026","journal-title":"Cells"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03330-2","article-title":"Integrated single-cell and spatial transcriptomic profiling reveals that CD177+ Tregs enhance immunosuppression through apoptosis and resistance to immunotherapy in hepatocellular carcinoma","volume":"44","author":"Liang","year":"2025","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1661545","article-title":"Infiltration characteristics and regulatory mechanisms of CD8+ T lymphocytes in solid tumors: spatial distribution, biological functions, and interactions with the immune microenvironment","volume":"16","author":"Ouyang","year":"2025","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/mc.70058","article-title":"Single-cell and spatial transcriptomic analysis reveals shared and cancer-type-specific cellular interactions and chemokine signaling associated with tertiary lymphoid structures in colorectal and gastric cancers","volume":"65","author":"Wang","year":"2026","journal-title":"Mol Carcinog"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1631226","article-title":"Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000600","article-title":"Spatial proximity of tumor-immune interactions predicts patient outcome in hepatocellular carcinoma","volume":"79","author":"Maestri","year":"2024","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1449624","article-title":"Single-cell sequencing reveals cell heterogeneity and aberrantly activated pathways associated with microvascular invasion in hepatocellular carcinoma","volume":"13","author":"Cui","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3040","article-title":"Activated and exhausted MAIT cells foster disease progression and indicate poor outcome in hepatocellular carcinoma","volume":"25","author":"Duan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12964-025-02070-w","article-title":"Molecular landscape of tumor-associated tissue-resident memory T cells in tumor microenvironment of hepatocellular carcinoma","volume":"23","author":"Park","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1038\/s41598-025-88377-7","article-title":"Single-cell landscape of dynamic changes in CD8+ T cells, CD4+ T cells and exhausted T cells in hepatocellular carcinoma","volume":"15","author":"Liu","year":"2025","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001740","article-title":"FYN\/LCK kinase balance as a metabolic switch orchestrates progenitor-exhausted T-cell differentiation in hepatocellular carcinoma","author":"Wu","year":"2026","journal-title":"Hepatology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1527421","article-title":"Pharmacological mechanisms of traditional Chinese medicine metabolites in regulating Treg cells: an integrative pathway review","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S562593","article-title":"Crosstalk between extracellular vesicles and regulatory T cells across cancers: From interaction to therapeutic potential","volume":"20","author":"Liu","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2024.102895","article-title":"Calreticulin regulates hepatic stellate cell activation through modulating TGF-beta-induced Smad signaling","volume":"121","author":"Chen","year":"2024","journal-title":"Cell Calcium"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1626708","article-title":"CXCL12\/CXCR4 axis governs Treg spatial dominance over CD8+ T cells via IL-2 sequestration: a dual therapeutic target in prostate cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013867","article-title":"Single-cell and spatial transcriptomics reveal that the CXCL12-CXCR4 axis drives the immune-desert phenotype in small cell lung cancer by recruiting immunosuppressive CXCR4+ neutrophils and S100A8+ monocytes","volume":"14","author":"Zeng","year":"2026","journal-title":"J Immunother Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251403904","article-title":"Unraveling the alterations and biomarkers in the tumor microenvironment in lung adenocarcinoma metastases and their indications for therapeutic response and prognosis","volume":"17","author":"Guan","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1757513","article-title":"Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities","volume":"17","author":"Zhang","year":"2026","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e22","article-title":"The diverse function of IL-6 in biological processes and the advancement of cancer","volume":"25","author":"Zhou","year":"2025","journal-title":"Immune Netw"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1682030","article-title":"From neuroinflammation to gliomagenesis: immune drivers of Malignant transformation in the CNS","volume":"16","author":"Bao","year":"2025","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.148526","article-title":"Value of CD8+ T cell-related genes and IL-6\/STAT3 signaling pathway in the prognosis of HCC and experimental investigation","volume":"332","author":"Wu","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3892\/ol.2025.15344","article-title":"CCL2\/CCR2 signaling pathway in tumorigenesis and metastasis (Review)","volume":"30","author":"Zhang","year":"2025","journal-title":"Oncol Lett"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1810902","article-title":"Chronic viral infections and their role in shaping the tumor immune microenvironment","volume":"17","author":"Li","year":"2026","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00825-z","article-title":"Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer","volume":"28","author":"Fang","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001021","article-title":"CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression","volume":"82","author":"Jeong","year":"2025","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1614228","article-title":"Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12964-025-02380-z","article-title":"Biomechanics of the tumor extracellular matrix and regulatory T cells: regulatory mechanisms and potential therapeutic targets","volume":"23","author":"Huang","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S570411","article-title":"Nanomedicines reshape the tumor microenvironment: Multidimensional strategies from modulating \"Barriers\" to metabolic intervention","volume":"21","author":"Zhao","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71769","article-title":"Tumor anti-angiogenesis therapy and its influence on immune cell function in the tumor microenvironment","volume":"15","author":"Tang","year":"2026","journal-title":"Cancer Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-025-01187-w","article-title":"Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy","volume":"25","author":"Lanitis","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1479505","article-title":"The role of interleukin-17 in inflammation-related cancers","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/med.70024","article-title":"The IL-23\/IL-17\/NF-\u03baB signaling pathway in rheumatoid arthritis: molecular mechanisms and therapeutic agents","volume":"46","author":"Deng","year":"2026","journal-title":"Med Res Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01293","article-title":"TRAF regulation of IL-17 cytokine signaling","volume":"10","author":"Swaidani","year":"2019","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor-based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00834.2025","article-title":"Tumor-associated macrophages: orchestrators of the tumor microenvironment","volume":"330","author":"Echols","year":"2026","journal-title":"Am J Physiol Cell Physiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i27.3346","article-title":"Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy","volume":"28","author":"Zhang","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/ijo.2026.5900","article-title":"Emerging agents that target signaling pathways in cancer fibroblast cells (Review)","volume":"69","author":"Wan","year":"2026","journal-title":"Int J Oncol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2026.06.001","article-title":"Molecular phenotypes and spatial archetypes: a new framework for cancer-associated fibroblasts","author":"Liu","year":"2026","journal-title":"Cancer Cell"},{"key":"B82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/cbin.12097","article-title":"Multifaceted TGF-\u03b2 signaling, a master regulator: from bench-to-bedside, intricacies, and complexities","volume":"48","author":"Ahuja","year":"2024","journal-title":"Cell Biol Int"},{"key":"B83","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00438-026-02472-6","article-title":"Single-cell transcriptomics identifies key immune-suppressive cells and their driver genes in the bladder cancer microenvironment with prognostic implications","volume":"301","author":"Song","year":"2026","journal-title":"Mol Genet Genomics"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1763769","article-title":"Recent advances in drug repurposing for cancer immunomodulation emerging strategies, mechanistic insights, and clinical translation","volume":"16","author":"Malik","year":"2026","journal-title":"Front Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1773233","article-title":"Metabolic reprogramming in tumor-associated cells of hematologic Malignancies: mechanisms, crosstalk networks, and therapeutic implications in the tumor microenvironment","volume":"17","author":"Hong","year":"2026","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1758873","article-title":"Innate immune recognition and microenvironmental reprogramming in HPV-induced cervical cancer: from pattern recognition receptor activation to immune tolerance disruption","volume":"16","author":"Khan","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/BS9.0000000000000149","article-title":"PD-L1: expression regulation","volume":"5","author":"Zhou","year":"2023","journal-title":"Blood Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.7150\/thno.106597","article-title":"Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"B91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s43556-026-00490-9","article-title":"Metabolic reprogramming in fibrosis-related diseases: underlying mechanisms and therapeutics","volume":"7","author":"Feng","year":"2026","journal-title":"Mol BioMed"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2025.101587","article-title":"Targeting hepatic stellate cell PD-L1 alters liver inflammation and fibrosis in CCl4 liver injury mouse model","volume":"19","author":"Bai","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202600972R","article-title":"C\u2014C motif chemokine ligand 7 promotes HSC-myofibroblast transition and liver fibrosis by enabling SREBP2-dependent cholesterologenesis","volume":"40","author":"Xiao","year":"2026","journal-title":"FASEB J"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.029","article-title":"Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B","volume":"76","author":"Gao","year":"2022","journal-title":"J Hepatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1277808","article-title":"Macrophages and platelets in liver fibrosis and hepatocellular carcinoma","volume":"14","author":"Casari","year":"2023","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000414","article-title":"Epigenetic memory of environmental exposures as a mediator of liver disease","volume":"80","author":"Hlady","year":"2024","journal-title":"Hepatology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155465","article-title":"Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2\/GPX4 signaling pathway","volume":"128","author":"Xu","year":"2024","journal-title":"Phytomedicine"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1343523","article-title":"Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy","volume":"11","author":"Piwocka","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073778","article-title":"Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options","volume":"23","author":"Sas","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.01.007","article-title":"Fueling HCC dynamics: interplay between tumor microenvironment and tumor initiating cells","volume":"15","author":"Huang","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218450","article-title":"Targeting the aHSC-PGE2-NK cell axis overcomes immunosuppression and inhibits liver metastasis in fibrotic liver","volume":"652","author":"Tang","year":"2026","journal-title":"Cancer Lett"},{"key":"B104","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12032-025-03220-3","article-title":"Single-cell profiling reveals lineage-specific fibroblast stromal subtypes drive ECM remodeling and immune modulation in the hepatocellular carcinoma tumor microenvironment","volume":"43","author":"Jiang","year":"2026","journal-title":"Med Oncol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1113378","article-title":"CAFs orchestrates tumor immune microenvironment-a new target in cancer therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.7150\/thno.90627","article-title":"Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-\u03b2 activity and CD8+ T-cell infiltration in breast cancer","volume":"14","author":"Honda","year":"2024","journal-title":"Theranostics"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1331641","article-title":"The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153826","article-title":"Chemokine receptor expression on T cells is modulated by CAFs and chemokines affect the spatial distribution of T cells in pancreatic tumors","volume":"14","author":"Gorchs","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-1690","article-title":"At the interface of tumor-associated macrophages and fibroblasts: immune-suppressive networks and emerging exploitable targets","volume":"30","author":"Timperi","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01731-z","article-title":"Roles of cancer-associated fibroblasts (CAFs) in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Pei","year":"2023","journal-title":"Mol Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.01.006","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma and cholangiocarcinoma","volume":"15","author":"Ying","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1369\/00221554211056853","article-title":"Current perspectives on the immunosuppressive niche and role of fibrosis in hepatocellular carcinoma and the development of antitumor immunity","volume":"70","author":"Aoki","year":"2022","journal-title":"J Histochem Cytochem"},{"key":"B114","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat Commun"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpt.2022.12.002","article-title":"Role of T cells in cancer immunotherapy: opportunities and challenges","volume":"1","author":"hmed","year":"2022","journal-title":"Cancer Pathog Ther"},{"key":"B116","doi-asserted-by":"publisher","first-page":"33","DOI":"10.20517\/cdr.2024.212","article-title":"Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC","volume":"8","author":"Franz\u00e8","year":"2025","journal-title":"Cancer Drug Resist"},{"key":"B117","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41419-026-08685-2","article-title":"Decoding the CAF-TAM axis: multi-omics dissection and therapeutic targeting of stromal-immune crosstalk in the tumor microenvironment","volume":"17","author":"Fu","year":"2026","journal-title":"Cell Death Dis"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol Rev"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1785587","article-title":"From immune exclusion to exhaustion: tumor microenvironment drives therapy response","volume":"17","author":"Maletin","year":"2026","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-0932","article-title":"YAP1 inhibition induces phenotype switching of cancer-associated fibroblasts to tumor suppressive in prostate cancer","volume":"84","author":"Song","year":"2024","journal-title":"Cancer Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2144669","article-title":"Chemokine switch regulated by TGF-\u03b21 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy","volume":"11","author":"Vienot","year":"2022","journal-title":"Oncoimmunology"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-0940","article-title":"Inhibition of JNK signaling overcomes cancer-associated fibroblast-mediated immunosuppression and enhances the efficacy of immunotherapy in bladder cancer","volume":"84","author":"Cui","year":"2024","journal-title":"Cancer Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1620075","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma: origins, heterogeneity, and therapeutic implications","volume":"16","author":"Shi","year":"2025","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1866753","article-title":"Cancer-associated fibroblasts in the lung cancer microenvironment from multi-dimensional mechanisms to therapeutic strategies","volume":"16","author":"Feng","year":"2026","journal-title":"Front Oncol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","article-title":"Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer","volume":"36","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1461424","article-title":"Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1690174","article-title":"Identification of CAF signature genes and construction of CAF-based risk signature in hepatocellular carcinoma by multi-omics analysis","volume":"16","author":"Qian","year":"2025","journal-title":"Front Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1723334","article-title":"Investigating the role of the TGF-\u03b2-SLC20A1 axis in the spatial heterogeneity of hepatocellular carcinoma through single-cell and spatial transcriptomics","volume":"17","author":"Li","year":"2026","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13073-024-01367-8","article-title":"Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma","volume":"16","author":"Jing","year":"2024","journal-title":"Genome Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1383932","article-title":"Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging","volume":"15","author":"Scheuermann","year":"2024","journal-title":"Front Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332837","article-title":"Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma","volume":"74","author":"Sali\u00e9","year":"2025","journal-title":"Gut"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0479","article-title":"Spatial dynamics of T- and B-cell responses predicts clinical outcome of resectable and unresectable hepatocellular carcinoma","volume":"30","author":"Kurebayashi","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0960","article-title":"Hepatocellular carcinoma immune microenvironment analysis: a comprehensive assessment with computational and classical pathology","volume":"30","author":"Ercan","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010975","article-title":"Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab","volume":"13","author":"Scheiner","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1710741","article-title":"Multi-omics spatial characteristics of CD8+TRM cells in hepatocellular carcinoma and immunotherapy response prediction","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1589563","article-title":"Integrative spatial and single-cell transcriptomics elucidate programmed cell death-driven tumor microenvironment dynamics in hepatocellular carcinoma","volume":"16","author":"Lei","year":"2025","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011648","article-title":"FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma","volume":"13","author":"Xu","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1804366","article-title":"Overcoming immune resistance in hepatocellular carcinoma: insights into mechanisms, predictive factors, and interventional strategies","volume":"17","author":"Wang","year":"2026","journal-title":"Front Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1808109","article-title":"Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside","volume":"17","author":"Zhang","year":"2026","journal-title":"Front Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1340702","article-title":"Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment","volume":"15","author":"Lv","year":"2024","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1340634","article-title":"Extracellular matrix remodeling in the tumor immunity","volume":"14","author":"Du","year":"2024","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1770031","article-title":"Notch signaling in liver diseases: mechanistic insights and therapeutic implications","volume":"14","author":"Shi","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1617662","article-title":"Cancer-associated fibroblast-mediated immune evasion: molecular mechanisms of stromal-immune crosstalk in the tumor microenvironment","volume":"16","author":"Luo","year":"2025","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1855429","article-title":"Immune-excluded and immune-suppressive tumor microenvironments: mechanisms, spatial biomarkers, and therapeutic rewiring","volume":"16","author":"Wang","year":"2026","journal-title":"Front Oncol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S581943","article-title":"Cancer-associated fibroblasts in the treatment of intrahepatic cholangiocarcinoma: present and prospects","volume":"13","author":"Yuan","year":"2026","journal-title":"J Hepatocell Carcinoma"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1177\/10732748251406674","article-title":"Macrophage polarization in the tumor microenvironment of hepatocellular carcinoma: from mechanistic insights to translational therapies","volume":"32","author":"Fu","year":"2025","journal-title":"Cancer Control"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1031","article-title":"Cancer-associated fibroblasts in inflammation and antitumor immunity","volume":"29","author":"Kennel","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1850149","article-title":"Tetrandrine enhances anti-PD-1 immunotherapeutic efficacy for hepatocellular carcinoma by activating STING\/TBK1\/IRF3 pathway","volume":"17","author":"Zheng","year":"2026","journal-title":"Front Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3880","article-title":"Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma","volume":"10","author":"Harding","year":"2021","journal-title":"Cancer Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1376551","article-title":"First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-\u00df1 complex, as monotherapy and in combination with the anti-PD-1 antibody budigalimab in patients with advanced solid tumors","volume":"14","author":"Shimizu","year":"2024","journal-title":"Front Oncol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1822947","article-title":"Subtype-dependent PD-L1 stability and immune context shape immunotherapy response in hepatocellular carcinoma","volume":"17","author":"Grisetti","year":"2026","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.187876","article-title":"LAG3-centered multiplex immune profiling as a prognostic biomarker in hepatocellular carcinoma patients receiving Anti-PD-1 antibodies plus lenvatinib therapy","volume":"16","author":"Zhang","year":"2026","journal-title":"Front Oncol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41392-026-02706-4","article-title":"Turning the clock: mRNA-encoded thymic factors restore aged immunity","volume":"11","author":"Khan","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1472430","article-title":"Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC","volume":"15","author":"Khan","year":"2024","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1930718\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:20:06Z","timestamp":1788787206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1930718\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":158,"alternative-id":["10.3389\/fimmu.2026.1930718"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1930718","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"1930718"}}